Three-Dimensional Recovery Framework
The three-dimensional model of post-craniotomy recovery: medical, cognitive, and emotional.
The Problem with One-Dimensional Recovery
Post-craniotomy follow-up currently operates on a single axis: medical outcomes. The scan is reviewed. The incision is inspected. The neurological exam is performed. When these are satisfactory, the clinical narrative becomes “you’re doing great” — even when the patient is not.
This creates what we call the medical-experience gap: the distance between what the chart says and what the patient lives. The MRI shows complete resection. The exam is non-focal. The patient sits in the parking lot afterward and cannot remember how to get home — not because of a neurological deficit, but because the cognitive and emotional weight of recovery has overwhelmed their capacity to function.
One-dimensional recovery assessment misses this entirely. And what we do not measure, we cannot treat.
The Three Dimensions
Dimension 1: Medical Recovery
What it tracks: Surgical site healing, tumor recurrence or residual, seizure control, medication management, neurological exam findings.
How it is measured: Imaging (MRI, CT), laboratory studies, physical examination.
When it is assessed: Standard follow-up intervals — typically 2 weeks, 6 weeks, 3 months, 6 months, and annually.
What it misses: Everything that happens between those appointments. Everything the patient experiences that does not appear on a scan or in a reflex test. Medical recovery is necessary but not sufficient — it tells you what happened to the brain, not what happened to the person.
Dimension 2: Cognitive Recovery
What it tracks: Memory, attention, executive function, language, processing speed.
How it is measured: MoCA (Montreal Cognitive Assessment), formal neuropsychological testing batteries.
The gap: Formal cognitive testing is often not performed after craniotomy. When it is, it captures performance in a controlled, quiet office setting — not real-world functional cognition. A patient may score normally on the MoCA while being unable to follow a conversation with multiple speakers, manage competing tasks at work, or make decisions under fatigue.
Perioperative neuropsychological testing is not routinely conducted due to resource constraints, language barriers, and a lack of understanding about its purpose. The result is that cognitive recovery goes unmeasured for most patients.
PCRES Domain B (Real-World Cognition) addresses this gap directly by asking patients about their cognitive function in the situations that actually matter to them.
Dimension 3: Emotional Recovery
What it tracks: Identity continuity, emotional regulation changes, grief for lost abilities, neurofatigue patterns, social connection disruption, the medical-experience gap itself, hope and agency.
How it is currently measured: Often, it is not. When emotional screening does occur, it typically relies on instruments designed for other populations — the PHQ-9 for depression, the GAD-7 for anxiety. These instruments were not built for post-craniotomy recovery and systematically misclassify neurological symptoms as psychiatric ones.
The critical distinction: A patient scoring high on the PHQ-9 after craniotomy may not be clinically depressed. They may be experiencing normal grief over lost abilities, identity disruption from neurological change, or neurofatigue that mimics depression — but requires entirely different clinical responses. Treating neurofatigue with an SSRI is not just ineffective; it communicates to the patient that their experience has been misunderstood.
The PCRES was designed specifically to capture the emotional dimension of recovery — the dimension that existing instruments cannot see.
How the Dimensions Interact
Recovery is not a single line moving upward. It is three trajectories that interact and sometimes diverge.
Divergent Recovery
A patient with excellent medical recovery but poor emotional recovery is not “doing well.” They are at risk for social withdrawal, medication non-adherence, and long-term quality of life impairment. Their chart looks perfect. Their life does not.
Resilient Recovery
A patient with slow medical recovery but strong hope and agency scores may have better long-term outcomes than their imaging suggests. Their internal resources are intact even when their medical trajectory is complicated.
Research from Leiden University Medical Center confirms this pattern: meningioma patients report clinically worse health-related quality of life than healthy controls, and this impairment persists years after surgery — even when medical outcomes are considered successful (Zamanipoor Najafabadi et al.). The medical dimension recovered. The person did not.
Understanding this interaction changes clinical practice. It means that a “successful surgery” is a necessary but incomplete measure of success. It means follow-up must assess all three dimensions to give an accurate picture of recovery.
Clinical Implications
The Three-Dimensional Follow-Up Visit
The three-dimensional model argues that follow-up visits should assess all three dimensions — not just the one we have always measured:
Medical assessment — Imaging review, neurological examination, medication management. This is what we already do well.
Cognitive screening — MoCA or equivalent, when indicated. 10 minutes.
Emotional assessment — PCRES administration (5–8 minutes), providing structured data on eight recovery domains that no other instrument captures.
Used alongside standard medical evaluation and cognitive screening, the PCRES gives clinicians a complete recovery picture in under 10 additional minutes per visit. Domain scores identify specific areas of concern. Clinical flags trigger specific actions. The two open-ended questions reveal what structured items miss.
The result is not more paperwork. It is better information — the kind that changes what you say to the patient, what referrals you make, and how you understand whether your patient is actually recovering.
References
Zamanipoor Najafabadi AH, et al. Impaired health-related quality of life in meningioma patients: a systematic review. Neuro-Oncology. Leiden University Medical Center.
Zamanipoor Najafabadi AH, et al. Health-related quality of life and neurocognitive functioning up to 4 years after intervention in intracranial meningioma patients. Neuro-Oncology. Leiden University Medical Center.
Studies documenting that perioperative neuropsychological testing is not routinely conducted due to resource constraints, language barriers, and institutional priorities.
Qualitative research showing patients feel the amount and quality of information received was insufficient, particularly regarding post-operative recovery and long-term life issues.
Whitney E. Still You: Emotional Recovery After Brain Surgery. 2025.